1.Histological Study of the Effect of Flos Carthami on Rabbit Atherosclerosis Following Cholesterol Diet.
Nak Jin PARK ; Nak Won SOHN ; Hak In LEE
Korean Journal of Physical Anthropology 1998;11(1):139-145
This study was aimed to investigate the effect of Flos Carthami on the atherosclerosis in rabbit induced by cholesterol diet. 24 rabbits were divided by 3 groups; normal control group, CH group, and CH+FC group. The normal control group was fed with the normal pellet diet. The CH group was fed with pellet diet including 4% cholesterol, and the CH+FC group was fed with pellet diet including 4% cholesterol and 4% Flos Carthami dry -extract powder about 100g diet per 1 kg body weight per a day. After 12 weeks, animals were sacrificed and a piece of ascending aorta was collected. Tissue was sectioned 8 micrometer thickness and sections were stained with hematoxylin -eosin, alcian blue pH 2.5, aldehyde -fuchsin, and Van Gieson 's trichrome method. In CH+FC group, atheroma and mucoprotein formation on tunica intima of the ascending aorta was reduced, and lesion of elastic and collagen fibers in tunica media was also attenuated with respect to that in CH group. According to this result, it is considered that Flos Carthami has a preventing effect on atherosclerosis or a control effect on hypercholesterolemia. But distinct mechanism of action is still unclear.
Alcian Blue
;
Animals
;
Aorta
;
Atherosclerosis*
;
Body Weight
;
Cholesterol*
;
Collagen
;
Diet*
;
Hematoxylin
;
Hydrogen-Ion Concentration
;
Hypercholesterolemia
;
Plaque, Atherosclerotic
;
Rabbits
;
Tunica Intima
;
Tunica Media
2.alpha-Asarone Ameliorates Memory Deficit in Lipopolysaccharide-Treated Mice via Suppression of Pro-Inflammatory Cytokines and Microglial Activation.
Jung Won SHIN ; Young Jin CHEONG ; Yong Mo KOO ; Sooyong KIM ; Chung Ku NOH ; Young Ha SON ; Chulhun KANG ; Nak Won SOHN
Biomolecules & Therapeutics 2014;22(1):17-26
alpha-Asarone exhibits a number of pharmacological actions including neuroprotective, anti-oxidative, anticonvulsive, and cognitive enhancing action. The present study investigated the effects of alpha-asarone on pro-inflammatory cytokines mRNA, microglial activation, and neuronal damage in the hippocampus and on learning and memory deficits in systemic lipopolysaccharide (LPS)-treated C57BL/6 mice. Varying doses of alpha-asarone was orally administered (7.5, 15, or 30 mg/kg) once a day for 3 days before the LPS (3 mg/kg) injection. alpha-Asarone significantly reduced TNF-alpha and IL-1beta mRNA at 4 and 24 hours after the LPS injection at dose of 30 mg/kg. At 24 hours after the LPS injection, the loss of CA1 neurons, the increase of TUNEL-labeled cells, and the up-regulation of BACE1 expression in the hippocampus were attenuated by 30 mg/kg of alpha-asarone treatment. alpha-Asarone significantly reduced Iba1 protein expression in the hippocampal tissue at a dose of 30 mg/kg. alpha-Asarone did not reduce the number of Iba1-expressing microglia on immunohistochemistry but the average cell size and percentage areas of Iba1-expressing microglia in the hippocampus were significantly decreased by 30 mg/kg of alpha-asarone treatment. In the Morris water maze test, alpha-asarone significantly prolonged the swimming time spent in the target and peri-target zones. alpha-Asarone also significantly increased the number of target heading and memory score in the Morris water maze. The results suggest that inhibition of pro-inflammatory cytokines and microglial activation in the hippocampus by alpha-asarone may be one of the mechanisms for the alpha-asarone-mediated ameliorating effect on memory deficits.
Animals
;
Cell Size
;
Cytokines*
;
Head
;
Hippocampus
;
Immunohistochemistry
;
Learning
;
Maze Learning
;
Memory
;
Memory Disorders*
;
Mice*
;
Microglia
;
Neurons
;
RNA, Messenger
;
Swimming
;
Tumor Necrosis Factor-alpha
;
Up-Regulation
3.alpha-Asarone Ameliorates Memory Deficit in Lipopolysaccharide-Treated Mice via Suppression of Pro-Inflammatory Cytokines and Microglial Activation.
Jung Won SHIN ; Young Jin CHEONG ; Yong Mo KOO ; Sooyong KIM ; Chung Ku NOH ; Young Ha SON ; Chulhun KANG ; Nak Won SOHN
Biomolecules & Therapeutics 2014;22(1):17-26
alpha-Asarone exhibits a number of pharmacological actions including neuroprotective, anti-oxidative, anticonvulsive, and cognitive enhancing action. The present study investigated the effects of alpha-asarone on pro-inflammatory cytokines mRNA, microglial activation, and neuronal damage in the hippocampus and on learning and memory deficits in systemic lipopolysaccharide (LPS)-treated C57BL/6 mice. Varying doses of alpha-asarone was orally administered (7.5, 15, or 30 mg/kg) once a day for 3 days before the LPS (3 mg/kg) injection. alpha-Asarone significantly reduced TNF-alpha and IL-1beta mRNA at 4 and 24 hours after the LPS injection at dose of 30 mg/kg. At 24 hours after the LPS injection, the loss of CA1 neurons, the increase of TUNEL-labeled cells, and the up-regulation of BACE1 expression in the hippocampus were attenuated by 30 mg/kg of alpha-asarone treatment. alpha-Asarone significantly reduced Iba1 protein expression in the hippocampal tissue at a dose of 30 mg/kg. alpha-Asarone did not reduce the number of Iba1-expressing microglia on immunohistochemistry but the average cell size and percentage areas of Iba1-expressing microglia in the hippocampus were significantly decreased by 30 mg/kg of alpha-asarone treatment. In the Morris water maze test, alpha-asarone significantly prolonged the swimming time spent in the target and peri-target zones. alpha-Asarone also significantly increased the number of target heading and memory score in the Morris water maze. The results suggest that inhibition of pro-inflammatory cytokines and microglial activation in the hippocampus by alpha-asarone may be one of the mechanisms for the alpha-asarone-mediated ameliorating effect on memory deficits.
Animals
;
Cell Size
;
Cytokines*
;
Head
;
Hippocampus
;
Immunohistochemistry
;
Learning
;
Maze Learning
;
Memory
;
Memory Disorders*
;
Mice*
;
Microglia
;
Neurons
;
RNA, Messenger
;
Swimming
;
Tumor Necrosis Factor-alpha
;
Up-Regulation
4.Human epidermal growth factor receptor 2 expression in gastric cancer patients treated with curative intent gastrectomy
Min Kyu KIM ; Sang Eok LEE ; Jang Sihn SOHN ; In Seok CHOI ; Ju Ik MOON ; Dae Sung YOON ; Ki Won CHUN ; Hye Yoon LEE ; Nak Song SUNG ; Si Min PARK ; Won Jun CHOI
Korean Journal of Clinical Oncology 2017;13(1):25-31
PURPOSE: This study aimed to clarify the association between human epidermal growth factor receptor 2 (HER-2) status and the clinicopathologic factors of patients who underwent curative intent gastrectomy.METHODS: From June 2011 to May 2015, curative intent gastrectomy was performed in 441 patients at Konyang University Hospital. Among them, we evaluated the HER-2 status in 113 patients. Data on clinicopathologic parameters such as age, sex, histological subtype, endoscopic Lauren classification, tumor location, size, presence of lymphovascular invasion, invasion depth, pathologic stage, HER-2 overexpression, recurrence and survival were obtained. In this study, pathological HER-2 intensity scores of 0, 1+, and 2+ were assumed to be negative, 3+ only was to be positive for overexpression.RESULTS: In a total of 113 cases who underwent curative intent gastrectomy with HER-2 testing, 16 (14.2%) cases had positivity of HER-2 overexpression. HER-2 overexpression had significant associations with tumor stage (19.0% in I-IIIb vs. 2.9% in IIIc-IV, P=0.036). Survival analysis of HER2 overexpression has no significant difference.CONCLUSION: In this study, HER-2 overexpression rate was 14.2% and patient tumor stage had significant association with HER-2 overexpression.
Classification
;
Epidermal Growth Factor
;
Gastrectomy
;
Humans
;
Receptor, Epidermal Growth Factor
;
Recurrence
;
Stomach Neoplasms